20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Ethoxymethylenemalononitrile (CAS 123-06-8): A Key Intermediate for Heterocyclic Chemistry

Ethoxymethylenemalononitrile (EMMN), bearing the CAS number 123-06-8, is a compound of immense importance in the field of heterocyclic chemistry. Its unique structural features enable it to serve as a critical precursor for synthesizing a broad spectrum of heterocyclic systems, which are the backbone of many pharmaceuticals and functional materials. NINGBO INNO PHARMCHEM CO.,LTD. is a leading provider of this essential intermediate, ensuring consistent availability and high quality for researchers and manufacturers worldwide.

The significance of EMMN in constructing diverse molecular frameworks cannot be overstated. Its reactivity profile makes it an ideal starting material for cyclization reactions, leading to the formation of complex ring structures. This makes understanding the various ethoxymethylenemalononitrile uses paramount for chemists aiming to innovate in areas like drug discovery and material science. The straightforward ethoxymethylenemalononitrile preparation, often involving common reagents, further enhances its accessibility.

As a vital component in organic synthesis, Ethoxymethylenemalononitrile facilitates the creation of compounds with potent biological activities. For instance, it is instrumental in the synthesis of pyrazoles, pyrimidines, and other nitrogen-containing heterocycles, many of which are found in leading pharmaceutical drugs. The ability to buy Ethoxymethylenemalononitrile from a reliable supplier like NINGBO INNO PHARMCHEM CO.,LTD. allows for the seamless integration of this intermediate into complex synthetic strategies.

Our expertise at NINGBO INNO PHARMCHEM CO.,LTD. lies in not only supplying high-purity Ethoxymethylenemalononitrile but also in understanding its role within broader chemical synthesis frameworks. We assist clients in leveraging the potential of malononitrile derivatives to develop cutting-edge products. Whether you are engaged in academic research or industrial-scale production, our commitment is to provide the chemical intermediates you need to succeed.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Exploring the Synthesis and Applications of Ethoxymethylenemalononitrile (CAS 123-06-8)

Next: The Role of Ethoxymethylenemalononitrile (CAS 123-06-8) in Pharmaceutical Intermediates and Beyond

All Rights Reserved